Apellis Pharmaceuticals general counsel Watson sells $101,103 in stock
David O. Watson, General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold shares of the company amounting to $101,103. The transaction, which occurred on January 22, 2025, ...
Apellis Pharmaceuticals chief scientific officer sells shares worth $120,119
Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.9 billion and currently trading near ...